Lung Cancer Immunotherapy
Breakthrough treatments for longer life
As the most common cancer worldwide, lung cancer impacts approximately 2.1 million people each year. Hope for millions is on the horizon as the lung cancer death rate in the United States has dropped dramatically over the last few years with the introduction of new treatments, including immunotherapy. Immunotherapy for lung cancer, alone or in combination with conventional treatments, can significantly improve outcomes for lung cancer patients. Join medical oncologist Dr. Julie Brahmer, of Johns Hopkins Medicine, to hear about several recently approved immunotherapy options and ask your questions about how immunotherapy is advancing the treatment of lung cancer. We’ll discuss PD-L1 expression, treatment response, length of treatment, clinical trials, and more.
Pancreatic Cancer Immunotherapy
Prostate Cancer Immunotherapy
Intro to CRI
Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer
Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments
Patient Perspectives: Immunotherapy and Clinical Trial Experiences
Bladder Cancer Immunotherapy
Gynecologic Cancer Immunotherapy
Liver Cancer Immunotherapy
Skin Cancer and Melanoma Immunotherapy
Understanding and Overcoming Barriers to Accessing Cancer Care
Blood Cancer Immunotherapy
Breast Cancer Immunotherapy
Colorectal Cancer Immunotherapy
Kidney Cancer Immunotherapy
Go back to event page
Hosts
Tamron Hall
Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist
CRI Experts
Julie Brahmer, MD
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Andrea Cercek, MD
Memorial Sloan Kettering Cancer Center
Luis Diaz Jr., MD
Memorial Sloan Kettering Cancer Center
Peter E. Fecci, MD, PhD
Duke Cancer Center, DukeHealth, and Duke University
Lawrence Fong, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Matthew D. Galsky, MD
The Tisch Cancer Institute
Sangeeta Goswami, MD, PhD
The University of Texas MD Anderson Cancer Center
Elizabeth Ann Mittendorf, MD, PhD
Dana-Farber/Harvard Cancer Center
Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center
Joseph E. Ravenell, MD
Perlmutter Cancer Center NYU Langone Health
Marcel van den Brink, MD, PhD
Memorial Sloan Kettering Cancer Center
Ana I. Velázquez Mañana, MD MSc
UCSF Helen Diller Family Comprehensive Cancer Center
Robert H. Vonderheide, MD, DPhil
University of Pennsylvania Health System
Jennifer Wargo, MD, MMSc
The University of Texas MD Anderson Cancer Center
Jeffrey S. Weber, MD, PhD
Perlmutter Cancer Center NYU Langone Health
Theodore H. Welling, MD
Perlmutter Cancer Center NYU Langone Health
CRI ImmunoAdvocates
LaToya Bolds-Johnson, PA-C, CAQ-EM
Breast Cancer Advocate & Thriver
Stephen Estrada
Long-term Survivor of Stage 4 Colorectal Cancer
Stephanie Gangi
Breast Cancer Navigator
Sunshine Pegues
Lung Cancer Veteran
John White
Prostate Cancer Veteran
CRI Moderators
Brian Brewer
Cancer Research Institute
Sponsors
Gold
Silver
Contributor
Friend
Host Institutions
Request a clinical trials orientation appointment
Questions?
Contact
[email protected]